Hamed Kamal insider trades
Hamed Kamal has filed 5 Form 4s with the SEC that we hold, all for Spero Therapeutics, Inc. (SPRO), as Chief Medical Officer. Across all of them we count 0 purchases worth $0 and 2 sales worth $88.6K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 39,496 shares of Spero Therapeutics, Inc. worth $50.2K, dated 2023-09-13. The first filing on our record is dated 2022-09-14 and the latest 2024-02-05.
Spero Therapeutics, Inc. (SPRO)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-09-13 | S, sale reported on Form 4 | 39,496 | $50.2K | 2023-09-15 |
| 2024-02-02 | S, sale reported on Form 4 | 28,075 | $38.5K | 2024-02-05 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1946366) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms